ArticleBMC gastroenterology2026
Study on the diagnostic value of lipid and systemic inflammatory markers in colorectal adenomatous polyps and the construction of a diagnostic model.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveColorectal adenomatous polyps are well-recognized precancerous lesions of colorectal cancer. Early identification and clinial intervention are crucial for reducing the risk of colorectal cancer. This study aimed to systematically investigate the diagnostic value of lipid and systemic inflammatory markers in colorectal adenomatous polyps and to construct a predictive diagnostic model, thereby providing assistance for early clinical identification.
methodsThis retrospective study includes 220 patients with colorectal adenomatous polyps who underwent endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) in the Department of Gastroenterology at the Fourth Affiliated Hospital of Anhui Medical University between January 1, 2023 and December 31, 2023. Concurrently, 220 healthy controls undergoing physical examinations at the hospital's physical examination center during the same period are enrolled. This study aimed to analyze the diagnostic value of lipid indicators (cholesterol, triglycerides, high-density lipoprotein and low-density lipoprotein) and systemic inflammatory markers (NLR, PLR, MLR, SII, SIRI and AISI) in colorectal adenomatous polyps and to construct a diagnostic model to facilitate clinical diagnosis.
resultsBaseline data analysis revealed statistically significant differences between the adenoma group and the control group in terms of gender, age, body mass index (BMI), cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL) and systemic inflammatory markers (NLR, PLR, MLR, SII, SIRI and AISI). Univariate and multivariate logistic regression analyses identified male, age, TC, TG and NLR as serving as valuable diagnostic indicators in colorectal adenomatous polyps, with TG showing the highest diagnostic value. The diagnostic nomogram model was constructed using the aforementioned five independent predictors among the variables examined to demonstrate robust discrimination, calibration and clinical utility.
conclusionAbnormal lipid metabolism and systemic inflammatory status serve as valuable diagnostic indicators in colorectal adenomatous polyps. The diagnostic model integrating metabolic and inflammatory markers exhibits certain diagnostic predictive efficacy,which can serve as providing auxiliary support for non-invasive, early screening of colorectal adenomatous polyps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.